Christopher J. Kane

Q: What Schools Are Affiliated With Christopher J. Kane

Christopher J. Kane is affiliated with the following schools: University of California, San Diego, University of California, San Francisco, University of Pennsylvania

Christopher J. Kane's AcademicInfluence.com Rankings

Christopher J. Kane

Biology

#10830

World Rank

#14188

Historical Rank

Genetics

#1160

World Rank

#1259

Historical Rank

Molecular Biology

#1615

World Rank

#1643

Historical Rank

biology Degrees

Download Badge

Biology

Christopher J. Kane's Degrees

PhD Molecular Biology University of California, San Francisco
Bachelors Biochemistry University of California, Berkeley

Why Is Christopher J. Kane Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Christopher J. Kane's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Molecular Taxonomy of Primary Prostate Cancer (2015) (2116)
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. (2019) (1026)
Prostate Cancer, Version 1.2016. (2016) (586)
Time to stone passage for observed ureteral calculi: a guide for patient education. (1999) (468)
Active surveillance for the management of prostate cancer in a contemporary cohort (2008) (411)
Renal cell cancer stage migration (2008) (410)
Immunosuppressive plasma cells impede T cell-dependent immunogenic chemotherapy (2015) (408)
Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. (2004) (398)
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. (2007) (332)
Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology (2014) (277)
Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. (2005) (254)
Prostate cancer, version 2.2014. (2014) (252)
Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. (2003) (250)
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. (2019) (236)
Prospective comparison of unenhanced spiral computed tomography and intravenous urogram in the evaluation of acute flank pain. (1998) (209)
Impact of body weight on urinary electrolytes in urinary stone formers. (2000) (202)
Saw palmetto for benign prostatic hyperplasia. (2006) (182)
Immediate and postoperative complications of transurethral prostatectomy in the 1990s. (1999) (172)
Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. (2006) (166)
Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. (2014) (166)
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. (2017) (160)
Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy (2006) (153)
Ureteral stenting after ureteroscopy for distal ureteral calculi: a multi-institutional prospective randomized controlled study assessing pain, outcomes and complications. (2001) (144)
Current management of severely encrusted ureteral stents with a large associated stone burden. (2000) (140)
Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. (2002) (139)
Tumor infiltrating B-cells are increased in prostate cancer tissue (2014) (137)
Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. (2005) (137)
Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. (2003) (134)
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. (2017) (133)
Incidence of bladder neck contracture after robot‐assisted laparoscopic and open radical prostatectomy (2010) (131)
Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. (2001) (130)
Multi-institutional experience with buccal mucosa onlay urethroplasty for bulbar urethral reconstruction. (2002) (130)
A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group (2001) (125)
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. (2006) (124)
Statin medication use and the risk of biochemical recurrence after radical prostatectomy (2010) (120)
Positive Surgical Margins in the 10 Most Common Solid Cancers (2018) (117)
Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. (2000) (115)
Multigene Methylation Analysis for Detection and Staging of Prostate Cancer (2005) (114)
Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. (2014) (113)
Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. (2004) (107)
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10 (2006) (107)
Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. (2002) (106)
Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database (2014) (106)
Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. (2008) (105)
Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. (2007) (104)
Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. (2003) (97)
Ethnic group‐related differences in CpG hypermethylation of the GSTP1 gene promoter among African‐American, Caucasian and Asian patients with prostate cancer (2005) (97)
Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. (2004) (96)
Treatment trends for stage I renal cell carcinoma. (2011) (91)
Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. (2000) (88)
CpG Hypermethylation of MDR1 Gene Contributes to the Pathogenesis and Progression of Human Prostate Cancer (2004) (86)
Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer (2005) (84)
Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database (2013) (82)
Feasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgery (2010) (82)
Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. (2007) (81)
The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. (2003) (81)
Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. (2005) (80)
Obstructive lower urinary tract symptoms correlate with erectile dysfunction. (2004) (79)
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens. (2017) (78)
Obesity is associated with castration‐resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database (2012) (78)
Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. (2003) (77)
Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration‐resistant prostate cancer, and mortality after radical prostatectomy (2014) (76)
Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. (2008) (75)
The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). (2005) (73)
Predicting Time From Metastasis to Overall Survival in Castration‐Resistant Prostate Cancer: Results From SEARCH (2017) (72)
Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. (2011) (72)
Intraoperative cell salvage in radical retropubic prostatectomy. (2001) (71)
Changing nature of high risk patients undergoing radical prostatectomy. (2007) (71)
Education predicts quality of life among men with prostate cancer cared for in the department of Veterans affairs (2007) (71)
Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. (2003) (70)
Management of isolated renal fossa recurrence following radical nephrectomy. (2005) (70)
Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. (2008) (70)
Current indications for open stone surgery in an endourology center. (1995) (69)
Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy. (2004) (67)
Obesity as a predictor of adverse outcome across black and white race (2009) (67)
Do younger men have better biochemical outcomes after radical prostatectomy? (2004) (66)
Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. (2010) (65)
Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation. (2019) (65)
Race, biochemical disease recurrence, and prostate–specific antigen doubling time after radical prostatectomy (2007) (64)
Laparoscopic partial nephrectomy with temporary arterial occlusion: description of technique and renal functional outcomes. (2004) (63)
A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. (2012) (63)
Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database. (2003) (62)
Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. (2008) (62)
Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 Genes in bladder cancer. (2002) (62)
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database. (2007) (62)
Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy (2013) (61)
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma (2006) (60)
Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. (2003) (59)
Ultrasonographic appearance of necrotizing gangrene: aid in early diagnosis. (1996) (58)
Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database (2013) (58)
Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. (2005) (58)
A detailed safety assessment of a saw palmetto extract. (2008) (56)
Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. (2006) (56)
Renal cell carcinoma in the pediatric population: Results from the California Cancer Registry (2008) (56)
Obesity and oncological outcome after radical prostatectomy: impact of prostate‐specific antigen‐based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases (2008) (56)
Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. (2004) (55)
The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy (2003) (55)
PGDB: a curated and integrated database of genes related to the prostate (2003) (55)
Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database. (2007) (54)
Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database, and analysis of changes in the PSA-era (2001) (53)
Predictors of Time to Metastasis in Castration-resistant Prostate Cancer. (2016) (52)
Methylation of the γ-Catenin Gene is Associated With Poor Prognosis of Renal Cell Carcinoma (2005) (52)
Yield of imaging and scintigraphy assessing biochemical failure in prostate cancer patients. (1997) (51)
Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. (2003) (51)
Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2008) (51)
Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer. (2019) (50)
Sildenafil citrate-associated priapism. (2000) (50)
CpG methylation at promoter site −140 inactivates TGFβ2 receptor gene in prostate cancer (2005) (49)
Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. (2016) (48)
Initial results from ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial. (2015) (48)
Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2014) (48)
Adequacy of lymphadenectomy among men undergoing robot‐assisted laparoscopic radical prostatectomy (2010) (47)
PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. (2008) (46)
Robotic-assisted simple prostatectomy: a systematic review and report of a single institution case series (2013) (45)
Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. (2003) (45)
Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review. (2017) (44)
Glycemic control and prostate cancer progression: Results from the SEARCH database (2010) (44)
Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG‐ACRIN 2805) Adjuvant Trial (2018) (44)
Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database (2009) (42)
Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805 (2015) (42)
Thresholds for PSA doubling time in men with non‐metastatic castration‐resistant prostate cancer (2017) (42)
Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year followup. (1998) (42)
Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. (2005) (42)
Age-dependent methylation of ESR1 gene in prostate cancer. (2004) (42)
Diabetes and Outcomes After Radical Prostatectomy: Are Results Affected by Obesity and Race? Results from the Shared Equal-Access Regional Cancer Hospital Database (2010) (42)
Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening. (2015) (41)
Predictors of prostate‐specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy (2004) (41)
Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI (2017) (41)
Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. (2009) (41)
Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE. (2003) (40)
Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2016) (40)
Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal‐access health care setting (2012) (38)
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. (2020) (38)
How to Minimize Lymphoceles and Treat Clinically Symptomatic Lymphoceles After Radical Prostatectomy (2014) (38)
Nerve-targeted probes for fluorescence-guided intraoperative imaging (2018) (37)
Erratum: Impact of body weight on urinary electrolytes in urinary stone formers (Urology 55: June 2000 (825-830)) (2000) (37)
Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database (2017) (36)
Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study. (2013) (35)
Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. (2012) (35)
A natural history of weight change in men with prostate cancer on androgen‐deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2011) (35)
Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer? (2016) (34)
Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research. (2002) (34)
Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate‐specific antigen levels (2004) (34)
The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy. (2001) (34)
Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma. (2006) (34)
Inactivation of the hMSH3 mismatch repair gene in bladder cancer. (2004) (34)
Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database. (2008) (33)
Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. (2007) (32)
Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. (2020) (32)
Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model (2012) (32)
The role of transesophageal echocardiography in rapid diagnosis and treatment of migratory tumor embolus. (2004) (31)
A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions (2011) (31)
Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score? (2006) (31)
Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database. (2010) (31)
Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial nephrectomy. (2011) (31)
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH. (2007) (30)
Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension (2015) (30)
Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database (2018) (29)
Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database (2009) (29)
The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database (2008) (28)
HIV and prostate cancer: a systematic review of the literature (2009) (27)
MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens (2015) (27)
Effect of BMI on primary treatment of prostate cancer. (2008) (27)
Race and Time from Diagnosis to Radical Prostatectomy: Does Equal Access Mean Equal Timely Access to the Operating Room?—Results from the SEARCH Database (2009) (27)
Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer (2015) (27)
Erdheim-Chester disease: case report and review of associated urological, radiological and histological features. (2003) (27)
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer (2016) (26)
Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease Research. (2003) (26)
Prostate diffusion imaging with distortion correction. (2015) (26)
The impact of pathologic staging on the long‐term oncologic outcomes of patients with clinically high‐risk prostate cancer (2014) (26)
Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. (2003) (26)
Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion (2017) (26)
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management (2022) (26)
Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1 (2008) (25)
What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group. (2008) (25)
Definition and preoperative predictors of persistently elevated prostate‐specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2010) (25)
Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes (2013) (25)
Number of Unfavorable Intermediate‐Risk Factors Predicts Pathologic Upstaging and Prostate Cancer‐Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database (2017) (24)
Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database. (2014) (24)
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? (2009) (24)
Effects of hospital procedure volume and resident training on clinical outcomes and resource use in radical retropubic prostatectomy surgery in the Department of Veterans Affairs. (2008) (24)
Comparison of rates and risk factors for development of anaemia and erythropoiesis‐stimulating agent utilization after radical or partial nephrectomy (2012) (24)
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer (2018) (24)
Pelvic lymphadenectomy in prostate cancer (2008) (24)
Exposure to Agent Orange is a significant predictor of prostate‐specific antigen (PSA)‐based recurrence and a rapid PSA doubling time after radical prostatectomy (2009) (24)
Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2010) (23)
Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. (2006) (23)
Obesity, race, and long‐term prostate cancer outcomes (2020) (23)
Restriction spectrum imaging improves MRI-based prostate cancer detection (2016) (23)
Positive surgical margins in radical prostatectomy patients do not predict long‐term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort (2016) (22)
Factors predicting skeletal‐related events in patients with bone metastatic castration‐resistant prostate cancer (2017) (22)
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma. (2021) (22)
Medical Undistancing Through Telemedicine: A Model Enabling Rapid Telemedicine Deployment in an Academic Health Center During the COVID-19 Pandemic. (2020) (22)
Management of pelvic lymphoceles following robot-assisted laparoscopic radical prostatectomy (2012) (22)
Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE. (2006) (22)
Partial orchiectomy and testis intratubular germ cell neoplasia: World literature review (2011) (21)
Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort (2016) (21)
Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes (2017) (21)
Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men? (2007) (21)
Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database. (2010) (20)
Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2011) (20)
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis. (2019) (20)
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. (2009) (19)
Update of staging and risk assessment for prostate cancer patients (2004) (19)
Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database. (2008) (19)
Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis (2016) (19)
Does PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group. (2011) (18)
Poorly controlled diabetes increases the risk of metastases and castration‐resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database (2019) (18)
Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease? (2015) (18)
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer (2020) (18)
Validation of the 2015 prostate cancer grade groups for predicting long‐term oncologic outcomes in a shared equal‐access health system (2017) (18)
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI (2016) (18)
Testicular infarction associated with sickle cell disease. (1998) (18)
Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. (2013) (18)
Unenhanced helical computed tomography in the evaluation of acute flank pain. (2000) (17)
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database. (2008) (17)
Effects of body mass on nicotine-induced thermogenesis and catecholamine release in male smokers. (2002) (17)
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence. (2017) (17)
Robotic-assisted fluorescence sentinel lymph node mapping using multimodal image guidance in an animal model. (2014) (17)
Minimally invasive cystectomy is associated with improved perioperative patient safety outcomes compared with open cystectomy in a national cohort. (2014) (17)
Lymph node dissection during robot-assisted radical prostatectomy: where do we stand? (2009) (17)
Do all men with pathological Gleason score 8–10 prostate cancer have poor outcomes? Results from the SEARCH database (2016) (16)
The effect of kidney morcellation on operative time, incision complications, and postoperative analgesia after laparoscopic nephrectomy. (2006) (16)
Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database. (2019) (16)
Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database (2009) (16)
Feasibility of transrectal hybrid natural orifice transluminal endoscopic surgery (NOTES) nephrectomy in the cadaveric model. (2012) (15)
Local Recurrence Following Resection of Intermediate-High Risk Non-metastatic Renal Cell Carcinoma: An Anatomic Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. (2020) (15)
Voxel Level Radiologic–Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer (2016) (15)
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer. (2008) (15)
Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts. (2020) (14)
Prostate‐specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database (2015) (14)
Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database (2016) (14)
Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database. (2012) (14)
Does early prostate‐specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group (2009) (14)
Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database (2014) (14)
Comparison of transrectal and transvaginal hybrid natural orifice transluminal endoscopic surgery partial nephrectomy in the porcine model. (2013) (14)
Does radical nephrectomy increase the risk of erectile dysfunction compared with partial nephrectomy? A cohort analysis (2013) (14)
Keratinizing desquamative squamous metaplasia of the kidney mimicking transitional cell carcinoma. (1998) (14)
Obesity, risk of biochemical recurrence, and prostate‐specific antigen doubling time after radical prostatectomy: results from the SEARCH database (2018) (14)
TRANSURETHRAL PROSTATECTOMY: IMMEDIATE AND POSTOPERATIVE COMPLICATIONS IN THE 1990's (1999) (14)
Predictors of operative time during radical retropubic prostatectomy and robot‐assisted laparoscopic prostatectomy (2017) (14)
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up (2022) (14)
Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital (2018) (13)
The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases (2010) (13)
Preclinical Evaluation of Robotic-Assisted Sentinel Lymph Node Fluorescence Imaging (2014) (13)
The Influence of Hepatic Function on Prostate Cancer Outcomes Following Radical Prostatectomy (2010) (13)
Adenocarcinoma of the prostate metastatic to the choroid of the eye (1995) (13)
Voiding dysfunction in human immunodeficiency virus infections. (1996) (13)
Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer (2017) (13)
Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database (2013) (13)
Initial experience with aspirin use during robotic radical prostatectomy. (2012) (12)
Validity of the National Death Index to Ascertain the Date and Cause of Death in Men Having Undergone Prostatectomy for Prostate Cancer (2019) (12)
Predictors of skeletal‐related events and mortality in men with metastatic, castration‐resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2019) (12)
Postoperative prostate‐specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases (2010) (12)
Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. (2018) (12)
What do I tell patients about saw palmetto for benign prostatic hyperplasia? (2011) (12)
CpG Hypermethylation of MDR 1 Gene Contributes to the Pathogenesis and Progression of Human Prostate Cancer (2004) (12)
Three‐month posttreatment prostate‐specific antigen level as a biomarker of treatment response in patients with intermediate‐risk or high‐risk prostate cancer treated with androgen deprivation therapy and radiotherapy (2018) (11)
Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH database (2010) (11)
Obese patients with castration‐resistant prostate cancer may be at a lower risk of all‐cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2018) (11)
A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy (2015) (11)
First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH database. (2018) (11)
Robot-assisted laparoscopic radical prostatectomy in men with human immunodeficiency virus (2010) (10)
In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database. (2016) (10)
Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2018) (10)
Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials (2021) (10)
Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database. (2007) (10)
Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database (2015) (10)
A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand (2021) (10)
Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve? (2016) (10)
PD43-02 ARE WE OPERATING ON WHO WE SHOULD? THE CHANGING CHARACTERISTICS OF RADICAL PROSTATECTOMY PATIENTS: RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2016) (10)
Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH database. (2015) (10)
Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival (2017) (10)
Initiation of salvage therapy for prostate cancer (2002) (10)
Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches. (2016) (9)
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier (2020) (9)
Re‐calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy (2009) (9)
Race does not predict the development of metastases in men with nonmetastatic castration‐resistant prostate cancer (2016) (9)
Racial Discrepancies in Overall Survival among Men Treated with Radium-223. (2019) (9)
The fate of 10-year clinically recurrence-free survivors after definitive radiotherapy for T1-3N0M0 prostate cancer. (1998) (9)
Cardiac safety analysis for a phase III trial of sunitinib (SU) or sorafenib (SO) or placebo (PLC) in patients (pts) with resected renal cell carcinoma (RCC). (2012) (9)
Validation of a bone scan positivity risk table in non‐metastatic castration‐resistant prostate cancer (2016) (9)
Adverse pathology and undetectable ultrasensitive prostate‐specific antigen after radical prostatectomy: is adjuvant radiation warranted? (2016) (9)
Watchful waiting versus active surveillance: Appropriate patient selection (2008) (8)
Competing Risks of Mortality Among Men with Biochemical Recurrence after Radical Prostatectomy. (2020) (8)
Erratum: Diffusion-Weighted imaging in cancer: Physical foundations and applications of restriction spectrum imaging (Cancer Research (2014) 74 (4638-4652)) (2014) (8)
Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer. (2019) (8)
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions (2022) (8)
Laparo-Endoscopic Single-Site Surgery for Radical and Cytoreductive Nephrectomy, Renal Vein Thrombectomy, and Partial Nephrectomy: A Prospective Pilot Evaluation (2010) (8)
Nerve-sparing Technique During Radical Prostatectomy and its Effect on Urinary Continence. (2016) (8)
Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma (2016) (7)
Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group (2017) (7)
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH (2017) (7)
Dose analysis of ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase 3 trial. (2015) (7)
Impact of renal surgery for cortical neoplasms on lipid metabolism (2014) (7)
Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? results from the SEARCH database (2003) (7)
Virtual reality suturing task as an objective test for robotic experience assessment (2015) (7)
NATIONAL TRENDS IN TREATMENT OF STAGE I RENAL CELL CARCINOMA (2009) (7)
Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer. (2019) (7)
1418: Can Hemodilution Explain the Lower PSA Concentrations Among Obese Men? (2007) (7)
Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort (2021) (6)
Is computed tomography a necessary part of a metastatic evaluation for castration‐resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database (2016) (6)
Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids (2022) (6)
Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease (2020) (6)
Characterization of a “low‐risk” cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database (2017) (6)
Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database (2019) (6)
African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance (2020) (6)
Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer (2016) (6)
Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy (2021) (5)
Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry (2022) (5)
Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer (2021) (5)
Methylation of the g -Catenin Gene Is Associated With Poor Prognosis of Renal Cell Carcinoma (2005) (5)
Agent Orange and long-term outcomes after radical prostatectomy. (2015) (5)
Surgery for Prostate Cancer: Rationale, Technique and Outcomes (2004) (5)
Assessment of central nervous system (CNS) and dose reduction events in patients treated with abiraterone acetate plus prednisone (AA+P) or enzalutamide (ENZ). (2016) (5)
Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database (2014) (4)
Robotic-Assisted Laparoscopic Prostatectomy for High-Risk Prostate Cancer: Technical Considerations and Review of the Literature (2011) (4)
Surgery for prostate cancer: rationale, technique and outcomes. (2002) (4)
Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV. (2020) (4)
Safety of concomitant therapy with radium‐223 and abiraterone or enzalutamide in a real‐world population (2021) (4)
Watchful waiting versus active surveillance: Appropriate patient selection (2009) (4)
Evaluation of a genomic classifier in primary tumor and lymph node metastases in pre- and post-radical prostatectomy tissue specimens from patients with lymph node positive prostate cancer. (2015) (4)
437: Obesity is an Independent Predictor of Biochemical Failure Following Radical Prostatectomy (2004) (4)
High serum folate is associated with reduced biochemical recurrence after radical prostatectomy: results from the SEARCH Database. (2013) (4)
Drug-seeking behavior in urolithiasis in the noncontrast computed tomography era: 2 cases. (1999) (4)
Laparoscopic radical cystectomy for cancer; oncologic outcomes for up to 5 years (2008) (4)
1162: Can Unilateral Prostate Cancer Be Reliably Predicted Based Upon Biopsy Features? (2006) (4)
Erratum: Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy (Cancer (2014), 120 (197-204)) (2015) (4)
Development and validation of a novel clinical-genomic risk group classification for prostate cancer incorporating genomic and clinicopathologic risk. (2017) (4)
Serum Lipids Prior to Starting Androgen Deprivation Therapy and Risk of Castration-Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database. (2020) (4)
Effect of adjuvant radiation therapy on urodynamic parameters following radical retropubic prostatectomy (1996) (4)
MP02-06 EVALUATION OF A GENOMIC CLASSIFIER IN RADICAL PROSTATECTOMY PATIENTS WITH LYMPH NODE METASTASIS (2016) (3)
Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH (2019) (3)
464: Is Obesity Associated with more Aggressive Prostate Cancer? (Data from Capsure) (2004) (3)
Renal imaging with spiral CT scan: clinical applications. (1997) (3)
241 DO NOMOGRAMS DESIGNED TO PREDICT BIOCHEMICAL RECURRENCE (BCR) DO A BETTER JOB OF PREDICTING MORE DISTANT PROSTATE CANCER OUTCOMES THAN BCR?–A REPORT FROM THE SEARCH DATABASE GROUP (2010) (3)
Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy (2019) (3)
First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH (2019) (3)
Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH (2020) (3)
Target Localization and Toxicity in Dose-Escalated Prostate Radiotherapy with Image-Guided Approach using Daily Planar Kilovoltage Imaging (2011) (3)
Does race predict the development of metastases in men who receive androgen‐deprivation therapy for a biochemical recurrence after radical prostatectomy? (2018) (3)
Commentary on "applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients." Wagener N, Nyarangi-Dix JN, Teber D, Zeier M, Hohenfellner M, Department of Urology, University of Heidelberg, Heidelberg, Germany: Transplant Proc 2012; 44(5):1287-92. (2013) (3)
Holmium:YAG laser lithotripsy of intrahepatic biliary calculi. (1999) (3)
What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders? (2014) (3)
PD10-04 LYMPHADENECTOMY AT THE TIME OF SURGERY FOR HIGH RISK LOCALIZED RCC: RESULTS FROM THE ASSURE ADJUVANT TRIAL (ECOG 2805) (2014) (3)
MP87-09 WHEN IS AN EQUIVOCAL BONE SCAN NOT REALLY EQUIVOCAL? RESULTS FROM SEARCH (2015) (3)
Experience with 10 years of a robotic surgery program at an Academic Medical Center (2021) (2)
Patient-level detection of grade group >=2 prostate cancer using quantitative diffusion MRI (2021) (2)
Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model (2012) (2)
Oral Scientific SessionsDevelopment and Validation of a Novel Clinical-Genomic Risk Group Classification for Prostate Cancer Incorporating Genomic and Clinicopathologic Risk (2017) (2)
904 PROSPECTIVE COMPARISON OF LAPARO-ENDOSCOPIC SINGLE-SITE SURGERY AND MULTIPORT LAPAROSCOPY FOR UPPER URINARY TRACT SURGERY: INITIAL OUTCOMES (2010) (2)
1637: A Randomized Controlled Trial of Saw Palmetto for the Treatment of Benign Prostatic Hyperplasia (2005) (2)
Kidney gene database: a curated and integrated database of genes involved in kidney disease. (2004) (2)
Laparoscopic removal of spermatic cord to reduce incision size of open retroperitoneal lymph node dissection. (2013) (2)
1636 LETHALITY OF PROSTATE CANCER IN A PRIMARY RELATIVE DOES NOT APPEAR TO INCREASE THE RISK OF AGGRESSIVE MALIGNANCY (2012) (2)
814 VARIATIONS IN INCIDENCE OF AND RISK FACTORS FOR DEVELOPMENT OF DIABETES MELLITUS AFTER RADICAL OR PARTIAL NEPHRECTOMY (2010) (2)
Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging (2022) (2)
Human immunodeficiency virus infection in urology (1997) (2)
Commentary on "anterior suspension combined with posterior reconstruction during robot-assisted laparoscopic prostatectomy improves early return of urinary continence: A prospective randomized multicentre trial." Hurtes X, Rouprêt M, Vaessen C, Pereira H, d'Arcier BF, Cormier L, Bruyère F, Urology D (2013) (2)
The Department of Defense center for prostate disease research. (2002) (2)
OBESITY AS A PREDICTOR OF ADVERSE OUTCOME ACROSS BLACK AND WHITE RACE: RESULTS FROM THE SEARCH AND DUKE PROSTATE CENTER DATABASES (2008) (2)
Potential drug-drug interaction events in patients treated with abiraterone acetate plus prednisone or enzalutamide. (2017) (2)
Renal Artery Embolism and Renal Vein Thrombosis (2013) (2)
Leveraging the Electronic Medical Record Improves Prostate Cancer Clinical Staging in a Community Urology Practice. (2020) (2)
1757 ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY AND CONCURRENT ASPIRIN USE. INITIAL EXPERIENCE (2010) (2)
860 DOES BEING ON ADT ALTER THE ABILITY OF PSA AND PSADT TO PREDICT A POSITIVE BONE SCAN? RESULTS FROM THE SEARCH DATABASE (2010) (2)
RISK STRATIFICATION AMONG MEN WITH POSITIVE SURGICAL MARGINS OR EXTRACAPSULAR DISEASE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2008) (2)
Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study (2021) (2)
Commentary on “Prospective randomized controlled trial of robotic vs. open radical cystectomy for bladder cancer: Perioperative and pathologic results” (2010) (2)
1508: Obesity, Serum PSA, and Prostate Size: Implications for Prostate Cancer Detection (2006) (2)
Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer. (2021) (2)
Controversial cases in endourology. (2005) (2)
Is Clinical Stage T 2 C Prostate Cancer Intermediate or High-Risk Disease ? (2015) (2)
2121 URINE MEASUREMENT OF TMPRSS2:ERG FOR THE EARLY DETECTION OF SIGNIFICANT PROSTATE CANCER (2010) (2)
COMPARISON OF RATES AND RISK FACTORS FOR DEVELOPMENT OF ANEMIA FOLLOWING RADICAL NEPHRECTOMY OR PARTIAL NEPHRECTOMY (2009) (2)
Urology in San Diego--its history in "America's finest city". (2013) (1)
Robotic assisted laparoscopic radical cystoprostatectomy: Operative and pathologic outcomes (2008) (1)
611: Baseline Characteristics and Predictors of Progression in an Active Surveillance Cohort: The UCSF Experience (2007) (1)
PD14-10 VALIDITY OF THE NATIONAL DEATH INDEX TO ACCURATELY CODE THE DATE OF DEATH AND DEATHS FROM PROSTATE CANCER, IN MEN HAVING UNDERGONE PROSTATECTOMY (2018) (1)
Saw palmetto for benign prostatic hyperplasia: Does it work any better than a placebo? (2007) (1)
Ten-Year Review of Robotic Surgery at an Academic Medical Center (2017) (1)
422: Polymorphisms of Cytochrome P450 1B1 are Risk Factors for Prostate Cancer (2004) (1)
1030: Do Younger Men have Better Biochemical Outcomes Following Radical Prostatectomy? (2004) (1)
DIABETES AND OUTCOMES AFTER RADICAL PROSTATECTOMY - ARE RESULTS AFFECTED BY OBESITY AND RACE? RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2009) (1)
Laparoscopic approaches to renal malignancies. (2006) (1)
MP53-01 THE RELATIONSHIP OF OBESITY, PATHOLOGIC GLEASON GRADE AND PROSTATE CANCER TUMOR VOLUME AT THE TIME OF RADICAL PROSTATECTOMY—RESULTS FROM THE SEARCH DATABASE (2015) (1)
2294 OBESE MEN ARE MORE LIKELY TO HAVE HIGHER PSA NADIR VALUES AFTER RADICAL PROSTATECTOMY (RP), THOUGH THIS DOES NOT EXPLAIN THE HIGHER BIOCHEMICAL RECURRENCE (BCR) RATES: RESULTS FROM THE SEARCH DATABASE (2011) (1)
Do Hispanic men have worse outcomes after radical prostatectomy? Results from SEARCH: Hispanic men outcomes: Results from SEARCH. (2020) (1)
Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the SEARCH database. (2015) (1)
Adult Urology Oncology: Adrenal/Renal/Upper Tract/Bladder Treatment Trends for Stage I Renal Cell Carcinoma (2011) (1)
B CELL CONCENTRATION IN HIGH RISK PROSTATE CANCER SPECIMENS AFTER NEOADJUVANT RITUXIMAB: MP70‐20 (2018) (1)
64 THE EFFECT OF RACE AND SOCIOECONOMIC STATUS ON SURGICAL MARGINS AND BIOCHEMICAL OUTCOMES IN AN EQUAL-ACCESS HEALTHCARE SETTING: RESULTS FROM THE SEARCH DATABASE (2012) (1)
770: Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Carcinogenesis Through Aberrant Wnt Signaling Activation (2005) (1)
MP78-03 PREDICTORS OF TIME TO METASTASIS IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2014) (1)
Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database (2021) (1)
Three-month post-treatment PSA as a biomarker of treatment response in intermediate or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy. (2018) (1)
Saw palmetto for benign prostatic hyperplasia - eScholarship (2006) (1)
Racial Differences in Prognostic Value of Adult Height for Biochemical Progression Following Radical Prostatectomy (2005) (1)
Free‐to‐total prostate‐specific antigen ratios 18–24 months following external beam radiation for adenocarcinoma of the prostate (1999) (1)
Impact of testosterone replacement therapy after radical prostatectomy on prostate cancer outcomes. (2019) (1)
Robotic prostatectomy improves outcomes--after the potentially risky adoption phase. (2012) (1)
MP34-11 OBESITY, RISK OF BIOCHEMICAL RECURRENCE, AND PSADT AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2018) (1)
RECALIBRATION AND EXTERNAL VALIDATION OF AN EXISTING NOMOGRAM TO PREDICT AGGRESSIVE RECURRENCES AFTER RADICAL PROSTATECTOMY (RP) (2009) (1)
Conservative Management of Ureteral Calculi (2007) (1)
Tumor infiltrating B-cells are increased in prostate cancer tissue (2014) (1)
DOES EARLY PSADT (EPSADT) AFTER RADICAL PROSTATECTOMY, CALCULATED PRIOR TO PSA RECURRENCE, CORRELATE WITH PROSTATE CANCER (PC) OUTCOMES? RESULTS FROM THE SEARCH DATABASE: PD40‐07 (2017) (1)
PREDICTIVE VALUE OF LEFT VENTRICULAR DIASTOLIC CHAMBER STIFFNESS IN PATIENTS WITH SEVERE AORTIC STENOSIS UNDERGOING AORTIC VALVE REPLACEMENT (2019) (1)
Do Racial Differences In Prostate Size Explain Higher Serum PSA Concentrations Among Black Men? (2012) (1)
Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned. (2021) (1)
Re: Saw Palmetto for Benign Prostatic Hyperplasia (2006) (1)
NCCN Prostate Cancer , Version 2 . 2014 Clinical Practice Guidelines in Oncology (2014) (1)
289 ASSOCIATION OF CIGARETTE SMOKING WITH TIME TO BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2010) (1)
Adoption of new technology and healthcare quality: Surgical margins after robotic prostatectomy (2008) (1)
Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database. (2012) (1)
886: Bladder Cancer Incidence and Risk Factors Among Men with Prostate Cancer: Results from Capsuretm (2006) (1)
PENILE CARCINOMA: RESULTS FROM THE CALIFORNIA CANCER REGISTRY (2009) (1)
2292 PSA NADIR DURING ANDROGEN DEPRIVATION THERAPY PREDICTS ADVERSE PROSTATE CANCER SPECIFIC OUTCOMES: RESULTS FROM THE SEARCH DATABASE (2011) (1)
The Impact of Comorbidity and Age on Timing of Androgen Deprivation Therapy in Men with Biochemical Recurrence after Radical Prostatectomy. (2018) (1)
Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? (2019) (1)
IS PSA A POOR PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL FAILURE FOLLOWING RADICAL PROSTATECTOMY IN OBESE MEN (2008) (1)
Prostate cancer: Risk versus benefit of lymph node dissection during prostatectomy (2013) (1)
1105: Stage Migration in Renal Cell Carcinoma Patients Demonstrated by Analysis of the National Cancer Database, 1993-2003 (2006) (1)
Incorporating robot-assisted prostatectomy at a Veterans Affairs hospital: outcomes. (2014) (1)
Race does not predict skeletal‐related events and all‐cause mortality in men with castration‐resistant prostate cancer (2020) (1)
478: Changing Practice Patterns in the Surgical Treatment of Kidney Disease: Analysis of the ACGME Data (2004) (1)
The Pan-Bcl-2 Family Inhibitor 97C1 Targets Blast Crisis Chronic Myeloid Leukemia Stem Cells but Spares Normal Cord Blood Progenitor Cells (2010) (1)
Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database (2016) (1)
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier (2020) (1)
BODY MASS INDEX AND PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY (2009) (1)
Combined inguinal hernia repair with prosthetic mesh during transperitoneal robot assisted laparoscopic radical prostatectomy: A 4-year experience (2008) (1)
PD35-12 NEOADJUVANT SUNITINIB IS ASSOCIATED WITH IMPROVED ONCOLOGIC OUTCOMES FOR PATIENTS WITH TUMOR THROMBUS IN RENAL CELL CARCINOMA: A MULTICENTER ANALYSIS (2015) (1)
Impact of age on treatment response in men with prostate cancer treated with radiotherapy (2021) (1)
STATIN MEDICATION USE AND THE RISK OF BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (1)
131: Agent Orange Exposure and Risk of Advanced Disease and Biochemical Progression after Radical Prostatectomy: Results from the Search Database (2006) (1)
Racial disparities in radium-223 treatment in a large real-world population. (2019) (1)
243: Ethnic Group-Related Differences in CPG Hypermethylation of the GSTP1 Gene Promoter among African American, Caucasian and Asian Patients with Prostate Cancer (2006) (1)
612: Pathologic Outcomes for Men on Active Surveillance who Undergo Radical Prostatectomy do not Differ from Men Undergoing Immediate Treatment (2007) (1)
Can Gleason 7 prostate cancer ever be low-risk? Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. (2015) (1)
WHAT ARE THE FACTORS ASSOCIATED WITH A SHORT PSA DOUBLING TIME? A REPORT FROM THE SEARCH DATABASE GROUP (2008) (1)
PD38-11 ADVERSE PATHOLOGY YET UNDETECTABLE ULTRASENSITIVE PSA: IS ADJUVANT RADIATION REALLY NECESSARY? (2015) (1)
MP81-19 MECHANISMS OF ANTI-ANDROGEN RESISTANCE IN A 3D PATIENT-DERIVED ORGANOID MODEL OF BONE METASTATIC PROSTATE CANCER (2019) (1)
606: Wnt Inhibitory Factor-1 Plays an Important Role in Pathogenesis of Bladder Cancer Through the Epigenetic Inactivation (2006) (1)
Title Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence : Results from the SEARCH Database (2016) (0)
Spectrum Imaging : An Evolving Imaging Biomarker in Prostate MRI Permalink (2017) (0)
Prostate Cancer: Localized VIIModerated Poster1465 DOES SALVAGE RADIATION THERAPY CHANGE THE BIOLOGY OF RECURRENT PROSTATE CANCER BASED ON PSA DOUBLING TIMES? RESULTS FROM THE SEARCH DATABASE (2012) (0)
392: Promoter Methylation of CYP1A1 Gene in Human Prostate Cancer (2005) (0)
MP67-09 RELATIONSHIP BETWEEN SKIN CANCER AND AGGRESSIVE PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2023) (0)
PSA VELOCITY (PSAV) TO CANCER-SPECIFIC PSA (PSA(PCA)) RATIO INCREASES WITH HIGHER GLEASON SCORE: RESULTS FROM THE SEARCH DATABASE (2008) (0)
1577: The Effect of Obesity on Prostate Cancer Treatment; Results from Capsure (2006) (0)
Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database (2021) (0)
A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort. (2023) (0)
1832 DOES TIMING OF TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA IMPACT TREATMENT TOXICITY AND SURGICAL COMPLICATIONS? A COMPARATIVE ANALYSIS OF PRIMARY AND ADJUVANT APPROACHES (2013) (0)
Reply by Authors. (2022) (0)
VALIDATION OF THE 2015 PROSTATE CANCER PROGNOSTIC GRADE GROUPS FOR PREDICTING LONG‐TERM ONCOLOGIC OUTCOMES IN A SHARED EQUAL ACCESS HEALTH SYSTEM.: PD03‐10 (2017) (0)
Re: Association of Black Race with Prostate Cancer-specific and Other-cause Mortality. (2021) (0)
Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease (2020) (0)
481: The Impact of Obesity on Secondary Treatment, Overall Survival, and Disease-Specific Survival in Men with Prostate Cancer: Results from Capsure (2006) (0)
Active surveillance: How to measure, manage, and improve. (2016) (0)
1638 UNILATERAL PROSTATE CANCER ANALYIS OF PREDICTORS IN SEARCH AND DUKE PROSTATE CENTER DATABASES (2012) (0)
Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database. (2015) (0)
1610: High-Risk Patients Undergoing Radical Prostatectomy Today are Less High-Risk than in the Past (2005) (0)
MP37-08 THE ASSOCIATION BETWEEN DIABETES AND PROSTATE CANCER-SPECIFIC MORTALITY IS DIFFERENT IN OBESE AND NON-OBESE MEN AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2020) (0)
1262: Men with Normal Pre-Operative Serum PSA Values have Better Biochemical Outcomes Following Radical Prostatectomy (2004) (0)
Refill gaps and dose reductions in patients treated with abiraterone acetate plus prednisone (AA+P) or enzalutamide (ENZ). (2017) (0)
Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database (2018) (0)
MP69-14 PERIOPERATIVE AND RENAL FUNCTIONAL OUTCOMES OF PARTIAL NEPHRECTOMY FOR COMPLEX RENAL SCORE WITH OR WITHOUT PRE-SURGICAL SUNITINIB: A MULTICENTER ANALYSIS (2015) (0)
661 RACE AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2010) (0)
388: Single Nucleotide Polymorphism (SNP) and Splicing Variant in C-Terminal Region of TCF-4 Gene are Related to the Pathogenesis of Prostate Cancer (2005) (0)
746: Epigenetics of Metallothionein-1G and Multidrug Resistance-1 Genes is a Common Feature of Human Bladder Cancer (2004) (0)
DO H2 BLOCKERS LOWER SERUM PSA RESULTS? - DATA FROM THE SEARCH DATABASE (2009) (0)
Abstract 1789: Pre-clinical studies to advance anti-ROR1 CAR-T cell therapy for metastatic prostate cancer (2023) (0)
NATURAL HISTORY OF PERSISTENTLY ELEVATED PSA AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
Title Impact of obesity on prostate cancer recurrence after radical prostatectomy : Data from CaPSURE Permalink (2005) (0)
IBJU | HigH serum folate is associated witH reduced biocHemical recurrence after radical prostatectomy : results from tHe searcH database 513 INtRODUctION Folate is a water-soluble (2013) (0)
MP87-08 IS COMPUTERIZED TOMOGRAPHY A NECESSARY PART OF A PROSTATE CANCER METASTATIC WORKUP? RESULTS FROM SEARCH (2015) (0)
VARIATIONS IN INCIDENCE OF AND RISK FACTORS FOR DEVELOPMENT OF OSTEOPOROSIS AND FRACTURES AFTER RADICAL OR PARTIAL NEPHRECTOMY (2009) (0)
IN MEN WITH CASTRATION‐RESISTANT PROSTATE CANCER VISCERAL METASTASES PREDICTS SHORTER OVERALL SURVIVAL: WHAT PREDICTS VISCERAL METASTASES? RESULTS FROM THE SEARCH DATABASE: PD24‐09 (2017) (0)
Commentary on Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: Oncological outcomes at 7 years (2009) (0)
Radium-223 treatment patterns in a large real-world population. (2019) (0)
480: Smoking Influences Aberrant CPG Hypermethylation of Multiple Genes in Human Prostate Cancer (2006) (0)
MP87-07 STATIN USE IS ASSOCIATED WITH IMPROVED PROSTATE CANCER-SPECIFIC OUTCOMES IN WHITE BUT NOT BLACK MEN INITIATING ANDROGEN DEPRIVATION THERAPY (2018) (0)
OUTCOME AMONG MEN WITH PATHOLOGICAL GLEASON SUM 8-10 PROSTATE CANCER AT THE TIME OF RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
PD32-10 POSITIVE SURGICAL MARGINS IN RADICAL PROSTATECTOMY PATIENTS DO NOT PREDICT LONG-TERM ONCOLOGICAL OUTCOMES: RESULTS FROM SEARCH (2015) (0)
Testosterone nadir and PSA recurrence-free survival in men with intermediate and high-risk localized prostate cancer undergoing definitive radiotherapy and androgen deprivation therapy. (2018) (0)
852 COMPARISON OF TRANSRECTAL AND TRANSVAGINAL HYBRID NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY (NOTES) PARTIAL NEPHRECTOMY IN THE PORCINE MODEL (2012) (0)
Commentary on Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy (2009) (0)
Obese men, higher PSA nadir values after radical prostatectomy (RP), and higher biochemical recurrence (BCR) rates: Results from the SEARCH database. (2011) (0)
393: African American Race, Risk of Biochemical Recurrence, and Psadt after Radical Prostatectomy (2007) (0)
MP36-13 NATIONAL TRENDS IN THE MANAGEMENT OF BENIGN RENAL MASSES: A 14-YEAR SURVEY OF THE NATIONWIDE INPATIENT SAMPLE (2014) (0)
683P Correlation between castration resistant prostate cancer (CRPC) free survival (CRPC-FS) and metastasis free survival (MFS) in men initiating androgen deprivation therapy (ADT) for biochemical recurrence (BCR) after radical prostatectomy (RP): Results from the SEARCH database (2020) (0)
Abstract 6109: Enzalutamide treatment of patient derived bone metastatic prostate cancer xenograft models implanted in the bone resulted in durable progression to castration resistant prostate cancer (CRPC) (2020) (0)
Low Penetrance Germline Genetic Testing: Role for Risk Stratification in Prostate Cancer Screening and Examples From Clinical Practice. (2020) (0)
Does salvage radiation therapy (SRT) change the biology of recurrent prostate cancer (PCa) based on PSA doubling times (PSADT)? Results from the SEARCH database. (2012) (0)
NATURAL HISTORY OF SALVAGE RADIOTHERAPY FOR RECURRENT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2009) (0)
1038: Percent of Prostate Needle Biopsy Cores with Cancer from the Most Involved Side of the Biopsy is a Better Predictor of PSA Recurrence Following Radical Prostatectomy than the Total Percent of Cores with Cancer (2004) (0)
MP52-02 CASTRATE RESISTANT GROWTH IN THE BONE NICHE OF NOVEL PATIENT-DERIVED XENOGRAFT MODELS OF BONE METASTATIC PROSTATE CANCER (2014) (0)
459: Obesity, Risk of Biochemical Recurrence, and PSADT after Radical Prostatectomy (2007) (0)
MP32-18 METABOLIC SYNDROME AND LONG-TERM PROSTATE CANCER OUTCOMES AFTER RADICAL PROSTATECTOMY (2021) (0)
Title Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer (2016) (0)
997 DELAYED RADICAL PROSTATECTOMY IN GLEASON 7 PROSTATE CANCER DECREASES TIME TO BIOCHEMICAL RECURRENCE: RESULTS FROM THE SEARCH DATABASE (2012) (0)
191: Quality of Life Differs by Education for Veterans: A Longitudinal Quality of Life Analysis from Capsure™ (2005) (0)
ANALYSIS OF THE PREDICTIVE UTILITY OF PROGNOSTIC GRADE GROUPS (PGG) FOR PREDICTING PERIOPERATIVE ONCOLOGIC OUTCOMES OF RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE: PD10‐11 (2017) (0)
719 SALVAGE RADIATION THERAPY AFTER RECURRENT PROSTATE CANCER: HOW EARLY DO WE NEED TO BE ? (2013) (0)
402: CPG Methylation at Promoter Site -140 Inactivates TGF- β Receptor Type II Gene Expression in Prostate Cancer (2005) (0)
Preparation for Prostate Biopsy (2013) (0)
Commentary on “Robot assisted partial nephrectomy vs. laparoscopic partial nephrectomy for renal tumors: A multi-institutional analysis of perioperative outcomes” (2010) (0)
MP58-12 SAFETY OF TESTOSTERONE REPLACEMENT AFTER RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: A POPULATION-BASED ANALYSIS (2019) (0)
Active Surveillance for Low Risk Prostate Cancer (2011) (0)
THE CLINICAL STAGE OF LOCALIZED PROSTATE CANCER IS OF NO PROGNOSTIC SIGNIFICANCE IN PREDICTING THE RISK OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2008) (0)
366 BIOPSY-DETECTED GLEASON PATTERN 5 PREDICTS RECURRENCE IN MEN WITH HIGH-RISK PROSTATE CANCER (2013) (0)
DEVELOPMENT AND VALIDATION OF NOVEL GENOMIC CLASSIFIERS FOR PREDICTION OF ADVERSE PATHOLOGY AFTER PROSTATECTOMY: MP57‐18 (2017) (0)
PD31-07 AGENT ORANGE AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY (2014) (0)
Emerging and Recently Described Subtypes of Renal Carcinoma (2016) (0)
MP42-09 PREDICTING BONE SCAN POSITIVITY IN CASTRATION-RESISTANT PROSTATE CANCER (2014) (0)
644 OBESITY IS ASSOCIATED WITH CASTRATE RESISTANT DISEASE AND METASTASIS IN MEN TREATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) FOR PSA-ONLY RECURRENCE AFTER RADICAL PROSTATECTOMY (RP): RESULTS FROM THE SEARCH DATABASE (2011) (0)
T1C DISEASE IN BLACK MEN: A MORE AGGRESSIVE DISEASE? RESULTS FROM THE SEARCH DATABASE (2008) (0)
328: Are the Partin Tables Accurate for African-American men in the United States? (2007) (0)
PD4-02 FLUORESCENCE LABELED TILMANOCEPT DETECTION OF SENTINEL LYMPH NODES DURING ROBOTIC SURGERY IN AN ANIMAL MODEL (2014) (0)
Commentary on An analysis of the causes of bladder neck contracture after open and robot-assisted laparoscopic radical prostatectomy (2009) (0)
Reply by Authors. (2019) (0)
536: Multi-Gene Methylation Analysis For Detection and Staging of Prostate Cancer (2006) (0)
450: CPG Hypermethylation of MDR1 Gene Contibutes to the Pathogenesis and Progression of Human Prostate Cancer (2005) (0)
NOVEL ECHO MEASURES OF LEFT VENTRICULAR AND MYOCARDIAL STIFFNESS (2019) (0)
DOES PRACTICE REFLECT THE EVIDENCE? LYMPH NODE DISSECTION WITH RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
1286: Are There Differences in Complications and Outcomes for Obese Patients Receiving Laparoscopic Nephrectomy? (2004) (0)
Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer (2019) (0)
Influence of Age on Treatment Outcomes in Intermediate or High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Radiation Therapy (2018) (0)
DYNAMIC SCREENING DETECTS PROSTATE CANCER (PC) EARLIER AND WOULD LEAD TO IMRPROVED CANCER CONTROL: RESULTS FROM THE DUKE PROSTATE CENTER AND THE SEARCH DATABASE (2008) (0)
902 PREDICTORS OF PROSTATE CANCER-SPECIFIC MORTALITY IN PATIENTS WITH RESIDUAL DISEASE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2011) (0)
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)? (2022) (0)
MP53-12 LONG TERM ONCOLOGICAL OUTCOMES OF APICAL POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) COHORT (2015) (0)
1990 PATHOLOGIC FINDINGS ON REPEAT PROSTATE BIOPSY FOR AN INITIAL DIAGNOSIS OF ATYPICAL GLANDS SUSPICIOUS FOR MALIGNANCY (2010) (0)
MP82-15 DOES EARLY ANDROGEN DEPRIVATION THERAPY AFTER BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY INCREASE OVERALL SURVIVAL? RESULTS FROM SEARCH (2015) (0)
Commentary on Tailoring technique of laparoscopic partial nephrectomy to tumor characteristics (2009) (0)
Title Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy : Results from the SEARCH database (2016) (0)
DOES EARLY PSADT, CALCULATED STARTING AT THE FIRST DETECTABLE PSA AFTER RADICAL PROSTATECTOMY (RP), CORRELATE WITH STANDARD PSADT? A REPORT FROM THE SEARCH DATABASE GROUP (2008) (0)
MP50-13 VALIDATION OF A BONE SCAN POSITIVITY RISK TABLE IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2016) (0)
MP57-03 IS ADVERSE PATHOLOGY AT THE TIME OF RADICAL PROSTATECTOMY A USEFUL PREDICTOR OF LONG-TERM OUTCOMES IN ACTIVE SURVEILLANCE CANDIDATES? RESULTS FROM THE SEARCH COHORT (2022) (0)
Association Between Finasteride use Prior to Prostate Cancer Diagnosis and Prostate Cancer-Specific Survival (2018) (0)
1465 RISK FACTORS FOR CARDIAC EVENTS AND CARDIAC MORTALITY FOLLOWING RADICAL AND PARTIAL NEPHRECTOMY (2013) (0)
Racial differences in E-cadherin expression and CpG methylation in prostate cancer (2004) (0)
PD28-05 FACTORS PREDICTING SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2016) (0)
MP14-18 AN ANATOMIC CLASSIFICATION SYSTEM FOR LOCAL RECURRENCE FOLLOWING RESECTION OF INTERMEDIATE AND HIGH RISK NON-METASTATIC RENAL CELL CARCINOMA: AN ANALYSIS OF THE ASSURE (ECOG-ACRIN 2805) TRIAL (2019) (0)
MP21-03 SERUM LIPID PROFILE AT TIME OF ANDROGEN DEPRIVATION THERAPY AND RISK OF CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2018) (0)
846: Is a Positive Bladder Neck Margin Truly a T4 Lesion in the PSA ERA? Results from the Search Database (2007) (0)
Abstract B72: Metformin use and risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database (2012) (0)
162 MULTI-INSTITUTIONAL VALIDATION OF THE CAPRA-S SCORE TO PREDICT OUTCOMES AFTER RADICAL PROSTATECTOMY (2012) (0)
Impact of testosterone replacement therapy after radiation therapy on prostate cancer outcomes. (2019) (0)
SOCIODEMOGRAPHIC AND CLINICAL RISK CHARACTERISTICS OF PATIENTS WITH PROSTATE CANCER WITHIN THE VETERANS AFFAIRS HEALTH CARE SYSTEM: DATA FROM C A PSURE (2003) (0)
1303 IMPACT OF RENAL SURGERY FOR CORTICAL NEOPLASMS ON LIPID METABOLISM (2013) (0)
Editorial Comment from Dr Liss and Dr Kane to Lymphocele after extraperitoneal robot‐assisted radical prostatectomy: A propensity score‐matching study (2013) (0)
Post-operative Image-guided Intensity-modulated Radiation Therapy for Prostate Cancer: Acute and Late Gastrointestinal and Genitourinary Toxicity (2009) (0)
MP22-06 SALVAGE RADIATION THERAPY FOR RECURRENT PROSTATE CANCER: CAN THE PROGNOSTIC GRADE GROUP SYSTEM INFORM TREATMENT TIMING? (2018) (0)
PD35-04 EFFECTS OF PERIOPERATIVE VARIABLES ON TIMING OF ADJUVANT RCC THERAPY: RESULTS FROM THE ASSURE TRIAL (ECOG 2805) (2015) (0)
Commentary on “Laparoendoscopic single-site surgery: Early experience with tumor nephrectomy” (2010) (0)
591: Age-Dependent Methylation of Estrogen Receptor Alpha in Prostate Cancer (2004) (0)
667: Pathological and Biochemical Outcomes after Radical Prostatectomy for Men with a Biopsy Gleason Score of 8 to 10 (2006) (0)
1464 EXTRACAPSULAR EXTENSION PREDICTS LATE RECURRENCE IN PATIENTS WHO ACHIEVE UNDETECTABLE PSA AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2011) (0)
PD16-10 RACE DOES NOT PREDICT SKELETAL RELATED EVENTS AND ALL-CAUSE MORTALITY IN MEN WITH CASTRATE RESISTANT PROSTATE CANCER (2020) (0)
PD04-10 PRE-CLINICAL STUDIES TO ADVANCE ZILOVERTAMAB-BASED ANTI-ROR1 DUAL SPECIFICITY CAR T-CELL THERAPY FOR METASTATIC PROSTATE CANCER. (2023) (0)
PREDICTORS OF CASTRATION RESISTANT PROSTATE CANCER IN MEN UNDERGOING SALVAGE ANDROGEN DEPRIVATION THERAPY - RESULTS FROM THE SEARCH DATABASE (2009) (0)
Sigmoid Perforation due to Toothpick Ingestion Leading to Hydronephrosis and Urosepsis (2015) (0)
MP32-15 COMPARISON OF THE PROSTATE CANCER COMORBIDITY INDEX AND AMERICAN ANESTHESIOLOGY ASSOCIATION SCORE IN PREDICTION OF MORTALITY IN MEN UNDERGOING RADICAL PROSTATECTOMY (2021) (0)
Title Active surveillance for the management of prostate cancer in a contemporary cohort Permalink (2008) (0)
PD34-07 CAN GLEASON 7 PROSTATE CANCER EVER BE LOW-RISK? RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2015) (0)
Abstract 880: Obesity predicts prostate cancer-specific mortality after radical prostatectomy: Results from the SEARCH database (2015) (0)
Radium-223 Utilization Patterns and Outcomes in Clinical Practice. (2022) (0)
SMALL TRUS VOLUME PREDICTS CLINICALLY SIGNIFICANT GLEASON SCORE UPGRADING AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
1648: Multi-Institutional Validation of the UCSF Cancer of the Rostate Risk Assessment (CAPRA) for Prediction of Recurrence Following Radical Prostatectomy (2006) (0)
DO NOMOGRAMS PREDICT AGGRESSIVE RECURRENCE AFTER RADICAL PROSTATECTOMY MORE ACCURATELY THAN BIOCHEMICAL RECURRENCE ALONE (2009) (0)
OVER THE LAST 15+ YEARS, THE PERCENTAGE OF MEN UNDERGOING RADICAL PROSTATECTOMY WHO ARE CANDIDATES FOR ACTIVE SURVEILLANCE HAS NOT CHANGED: RESULTS FROM THE SEARCH DATABASE (2008) (0)
PD54-05 HALSTEADIAN VIEW OF PROSTATE CANCER: DOES REMOVING MORE NODES AT RADICAL PROSTATECTOMY AFFECT BIOCHEMICAL RECURRENCE? (2022) (0)
VALIDATION OF STEPHENSON NOMOGRAM TO PREDICT PSA PROGRESSION FOLLOWING SALVAGE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
360 SHOULD CLINICAL STAGE T2C PROSTATE CANCER BE CLASSIFIED AS INTERMEDIATE- OR HIGH-RISK? - RESULTS FROM THE SEARCH DATABASE (2012) (0)
1121 UROLOGY IN SAN DIEGO - INSIGHTS INTO THE HISTORY OF UROLOGIC SURGEONS IN “AMERICA'S FINEST CITY” (2013) (0)
MP02-14 VOXEL LEVEL RADIOLOGIC-PATHOLOGIC VALIDATION OF RESTRICTION SPECTRUM IMAGING WITH GLEASON GRADE IN PROSTATE CANCER (2016) (0)
Mp79-15 Radical Prostatectomy and the Effect of Close Surgical Margins: Analysis From the Search Database (2013) (0)
Reply by Authors. (2019) (0)
Does salvage radiation therapy (SRT) change the biology of recurrent prostate cancer (PCa) based on PSA doubling times (PSADT)? Results from the SEARCH database. (2012) (0)
1109: An Increasing Proportion of Patients with Stage 1 Renal Cell Carcinoma May be Candidates for Focal Therapy: Analysis from the National Cancer Database, 1993-2003 (2006) (0)
1267 COMPARISON OF PARTIAL AND RADICAL NEPHRECTOMY IN STAGE II OR GREATER RENAL TUMORS (2011) (0)
2013 UC San Diego Department of Urology Newsletter (2013) (0)
Prostate Cancer: Localized (I)Podium Session 6357 RADICAL PROSTATECTOMY AND THE EFFECT OF CLOSE SURGICAL MARGINS: ANALYSIS FROM THE SEARCH DATABASE (2013) (0)
PD13-04 LONG-TERM COMPETING RISKS OF MORTALITY AMONG MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2020) (0)
Risk Stratification of Men with Gleason 7–10 tumors by Primary and Secondary Gleason Score: Results from the SEARCH Database (2012) (0)
Clinical characteristics of prostate cancer and benign prostate hypertrophy patients Prostate cancer (2005) (0)
2284 : Preoperative PSA Velocity Predicts for Relapse After Prostatectomy Only for Non-Obese (Low BMI) Patients (2006) (0)
MP34-08 AGGRESSIVE PROSTATE CANCER IN VETERANS WITH A PRIOR PSA OF ≤1.0 NG/ML (2018) (0)
997 RISK FOR RECURRENT PROSTATE CANCER INCREASES WITH CHOLESTEROL ON A CONTINUUM IN MEN WITH ABNORMAL CHOLESTEROL LEVELS - AN UPDATE FROM THE SEACH DATABASE (2011) (0)
MP34-13 COMBINATION THERAPY WITH RADIUM-223 AND ABIRATERONE OR ENZALUTAMIDE IN A LARGE REAL WORLD COHORT (2019) (0)
Editorial comment. (2014) (0)
WHAT ARE THE BEST CUT‐POINTS FOR PSA DOUBLING TIME IN MEN WITH NON‐METASTATIC CASTRATION‐RESISTANT PROSTATE CANCER?: MP20‐19 (2017) (0)
371: Polymorphisms of the CYP1B1 Gene as Risk Factors for Human Renal Cell Cancer (2005) (0)
Commentary on “Cost analysis of robotic vs. open radical cystectomy for bladder cancer” (2010) (0)
Commentary on Feasibility of laparoscopic partial nephrectomy after previous ipsilateral renal procedures (2009) (0)
1597: Adequacy of Lymphadenectomy Among Men Undergoing Robotic-Assisted Laparoscopic Radical Prostatectomy (2007) (0)
2060 DOES PSA DOUBLING TIME AFTER RADICAL PROSTATECTOMY CORRELATE WITH OVERALL SURVIVAL? A REPORT FROM THE SEARCH DATABASE GROUP (2010) (0)
MP33-03 DORMANT CASTRATION-RESISTANT PROSTATE CANCER ORGANOIDS WITH HYBRID BASAL-LUMINAL CELLS AND LOSS OF SARS-COV-2 HOST FACTORS EMERGED UNDER ANDROGEN DEPRIVATION (2021) (0)
Guest editorial: robotic techniques in urologic oncology (2013) (0)
1497 OVERSTAGING HIGH-RISK PROSTATE CANCER MAY LEAD TO OVERTREATMENT: RESULTS FROM THE SEARCH DATABASE (2013) (0)
Is biopsy Gleason sum an independent predictor of biochemical progression following radical prostatectomy after adjusting for the pathological Gleason sum? (2006) (0)
Active Surveillance for Low Risk Prostate Cancer, R.C.N. van den Bergh. Optima Grafi Sche Communicatie, Rotterdam, The Netherlands (2009), 225 pages (2011) (0)
MP54-14 TIME TRENDS IN USE OF RADICAL PROSTATECTOMY BY TUMOR RISK AND LIFE EXPECTANCY IN A NATIONAL VA COHORT FROM 2000 TO 2017 (2019) (0)
MP60-12 DOES LARGER TUMOR VOLUME EXPLAIN THE HIGHER PROSTATE SPECIFIC ANTIGEN LEVELS IN BLACK MEN WITH PROSTATE CANCER —RESULTS FROM THE SEARCH DATABASE (2015) (0)
474: Significance of the Apical Margin in Radical Prostatectomy: Results from the Search Database (2007) (0)
PD62-08 PREDICTED RISK OF PROSTATE CANCER-SPECIFIC MORTALITY ON ACTIVE SURVEILLANCE FOR MEN WITH FAVORABLE INTERMEDIATE RISK PROSTATE CANCER (2020) (0)
789: Inactivation of the Human MSH3 Mismatch Repair Gene in Bladder Cancer (2005) (0)
Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P and Freedland SJ. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration‐resistant prostate cancer, and mortality after radical prostatectomy. Cancer. 2014;120:1 (2015) (0)
389: CPG Hypermethylation of Adenomatous Polyposis Coli (APC) Promoter is a Candidate Biomarker to Predict Biological Aggressiveness of Localized Prostate Cancer (2005) (0)
451: Hypomethylation of the Heparanase Promoter in Prostate Cancer and its Positive Association with Early PSA Failure after Radical Prostatectomy (2005) (0)
849: In the Modern ERA, Classifying Localized Prostate Cancer as T1C VS. T2A is of no Prognostic Significance when Predicting the Risk of Biochemical Recurrence (2007) (0)
387: The Optimal Timing, Cutoff and Method of Calculation of Preoperative PSA Velocity to Predict Relapse after Prostatectomy: A Report from Search (2007) (0)
Commentary on “Management of rectal injury during robotic radical prostatectomy.” Kheterpal E, Bhandari A, Siddiqui S, Pokala N, Peabody J, Menon M, Vattikuti Urology Institute, Henry Ford Health System, Henry Ford Hospital, Detroit, Michigan (2012) (0)
Title: Patient-level detection of grade group ≥2 prostate cancer using quantitative diffusion MRI Authors: (2021) (0)
MP09-18 BIOPSY-DETECTED GLEASON PATTERN 5 IS A PARTICULARLY STRONG PREOPERATIVE PREDICTOR OF RECURRENCE, METASTASIS, AND MORTALITY IN MEN WITH HIGH-RISK PROSTATE CANCER (2016) (0)
338 DO REPEATED PROSTATE BIOPSIES WORSEN THE OUTCOME AMONG MEN WITH PROSTATE CANCER WHO HAVE A RADICAL PROSTATECTOMY? RESULTS FROM THE SEARCH DATABASE (2011) (0)
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer (2020) (0)
Sentinel lymph node mapping via fluorescence imaging of a multi-modal receptor-binding probe (2013) (0)
228: Cytochrome P450 1B1 is Over-Expressed and Regulated by Hypomethylation in Human Prostate Cancer (2005) (0)
Prostate Localization and Toxicity Outcomes for External Beam Prostate Cancer Radiotherapy using On-board kV X-ray Image Matching (2008) (0)
MP53-02 IS CLINICAL STAGE T2C PROSTATE CANCER INTERMEDIATE OR HIGH-RISK DISEASE? (2015) (0)
MP64-15 ASSOCIATION BETWEEN DELAY TO SURGERY AND CLINICALLY MEANINGFUL OUTCOMES AMONG PATIENTS WITH INTERMEDIATE- AND HIGH-RISK LOCALIZED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: AN ASSESSMENT OF THE SEARCH DATABASE WITH INSIGHT INTO THE ROLE OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY (2021) (0)
African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance (2020) (0)
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer (2017) (0)
PREDICTORS OF SECONDARY TREATMENT FOLLOWING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
WS3-4 Epigenetics of cell adhesion genes in human prostate cancer (2004) (0)
First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH (2019) (0)
292 DOES INITIATING STATIN THERAPY AFTER RADICAL PROSTATECTOMY REDUCE THE RISK FOR BIOCHEMICAL RECURRENCE? – RESULTS FROM THE SEARCH DATABASE (2010) (0)
16: Nerve Sparing Does not Increase the Risk of Biochemical Recurrence: Results from the Search Database (2007) (0)
Oncology Does Salvage Radiation Therapy Change the Biology of Recurrent Prostate Cancer Based on PSA Doubling Times? Results from the SEARCH Database (2012) (0)
Commentary on “Preoperative superselective transarterial embolization in laparoscopic partial nephrectomy: Technique, oncologic, and functional outcomes” (2010) (0)
Improving Toxicity Profiles with Dose-Escalated Image-Guided Radiation Therapy in Patients with Localized Prostate Cancer (2017) (0)
The Human T-Cell Factor-4 Gene Splicing Isoforms , Wnt Signal Pathway , and Apoptosis in Renal Cell Carcinoma 1 (2003) (0)
Title Renal cell cancer stage migration : Analysis of the National Cancer Data Base Permalink (2008) (0)
MP61-14 MICROCT ANALYSIS REVEALED BONE REGION-SPECIFIC LOCALIZATION OF OSTEOLYTIC VERSUS OSTEOBLASTIC LESIONS IN PCSD1, A NEW PATIENT-DERIVED XENOGRAFT MODEL OF BONE METASTATIC PROSTATE CANCER. (2015) (0)
1680 PREVALENCE AND RISK FACTORS FOR DEVELOPMENT OF METABOLIC SYNDROME AFTER RADICAL OR PARTIAL NEPHRECTOMY (2012) (0)
PD13-10 DIABETES AND PROSTATE CANCER OUTCOMES IN MEN WITH NONMETASTATIC CASTRATE-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH COHORT (2022) (0)
697: Prostate Size is Inversely Associated with Risk of High-Grade, Advanced Prostate Cancer, and Biochemical Progression Following Radical Prostatectomy (2005) (0)
HIGHER CHOLESTEROL INCREASES THE RISK OF BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE GROUP (2008) (0)
MP26-19 FURTHER DEFINING THE NATURAL HISTORY OF BIOCHEMICAL PROGRESSION FOLLOWING RADICAL PROSTATECTOMY: DOES PSA DOUBLING TIME CHANGE WITH TIME? (2021) (0)
NOMOGRAM BASED ON SEXTANT POSITIVE BIOPSY CORES, GLEASON SUM AND PRE-BIOPSY PSA TO PREDICT ORGAN CONFINEMENT IN RADICAL PROSTATECTOMY PATIENTS-A CENTER FOR PROSTATE DISEASE RESEARCH (CPDR) MULTI-CENTER STUDY (1999) (0)
MP90-06 FULL EXOME SEQUENCING, COPY NUMBER VARIATION AND TRANSCRIPTOME ANALYSES REVEALS DIVERSITY AND MUTATIONAL EVOLUTION IN A LONGITUDINAL SERIES OF SURGICAL PROSTATE CANCER BONE METASTASES FROM A PATIENT WITH PROGRESSIVELY THERAPY-RESISTANT CANCER. (2016) (0)
NOVEL RISK STRATIFICATION GROUPING USING STANDARD CLINICAL AND BIOPSY INFORMATION FOR PATIENTS UNDERGOING RADICAL PROSTATECTOMY: RESULTS FROM SEARCH: MP20‐02 (2017) (0)
MP57-14 CHANGE IN PLATELET COUNT AS A PROGNOSTIC INDICATOR FOR RESPONSE TO NEOADJUVANT TYROSINE KINASE INHIBITOR THERAPY IN METASTATIC RENAL CELL CARCINOMA (2014) (0)
457: Agent Orange Exposure among Black Men is a Stronger Predictor of PSA Recurrence and Rapid Post-Recurrence Psadt than among White Men (2007) (0)
MP32-05 CONTEMPORARY HISTORY OF PROGRESSION FOLLOWING ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2021) (0)
MP4-17 PATHOLOGIC GLEASON 8-10: DO ALL MEN DO POORLY? RESULTS FROM THE SEARCH DATABASE (2015) (0)
CLINICAL UTILITY OF MRI/FUSION BIOPSY IN PROSTATE CANCER PATIENTS ON ACTIVE SURVEILLANCE: MP43‐07 (2017) (0)
427: Racial Differences in β- and γ-Catenin Methylation Status in Prostate Cancer (2004) (0)
PD10-06 THE IMPACT OF PRIOR LOCAL THERAPY ON OVERALL SURVIVAL IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM SEARCH (2018) (0)
Upgrading and Downgrading of Prostate Needle Biopsies: Risk Factors and Clinical Implications (2011) (0)
Re: Metastatic adenocarcinoma of the prostate to the choroid with loss of visual acuity as a presenting symptom. (1999) (0)
MP14-12 OBESE CASTRATION-RESISTANT PROSTATE CANCER PATIENTS MAY BE AT A LOWER RISK OF METASTASIS AND ALL-CAUSE MORTALITY: RESULTS FROM THE SEARCH DATABASE (2015) (0)
1437 PARTIAL AND RADICAL NEPHRECTOMY IN STAGE II OR GREATER RENAL TUMORS: COMPARISON OF OUTCOMES STRATIFIED BY RENAL NEPHROMETRY SCORE (2012) (0)
GENOMIC ANALYSIS OF A LONGITUDINAL SERIES OF SURGICAL PROSTATE CANCER BONE METASTASES AND XENOGRAFTS FROM THE SAME PATIENT REVEALED SELECTION OF A PROGRESSIVELY THERAPY RESISTANT METASTATIC CLONE: MP87‐10 (2017) (0)
From a Randomized , Sham-Controlled Study Safety and Tolerability of High-Intensity Focused Ultrasonography for Noninvasive Body Sculpting : 24-Week (2012) (0)
Abstract A43: Novel prostate cancer patient-derived xenograft models of bone metastatic castrate-resistant prostate cancer (2014) (0)
Reply: To PMID 24958477. (2014) (0)
2262 INCIDENCE AND RISK FACTORS OF NEPHROLITHIASIS AFTER CHEMOTHERAPY IN PATIENTS WITH LYMPHOPROLIFERATIVE OR MYELOPROLIFERATIVE DISORDERS (2013) (0)
Editorial comment. (2009) (0)
Commentary on “Posterior reconstruction before vesicourethral anastomosis in patients undergoing robot-assisted laparoscopic prostatectomy leads to earlier return to baseline continence.” Brien JC, Barone B, Fabrizio M, Given R, Department of Urology, Eastern Virginia Medical School, Norfolk, Virgin (2012) (0)
DO SICKER PEOPLE HAVE WORSE PROSTATE CANCER‐SPECIFIC OUTCOMES AFTER RADICAL PROSTATECTOMY? RESULTS FROM SEARCH: PD40‐12 (2017) (0)
THE IMPACT OF SOCIOECONOMIC STATUS ON CLINICAL PARAMETERS OF RADICAL PROSTATECTOMY PATIENTS IN AN EQUAL ACCESS HEALTH CARE SYSTEM (1999) (0)
Receptor-seeking near-infrared radiopharmaceutical IRDye800CW-tilmanocept for multimodality sentinel lymph node imaging (2013) (0)
MP34-10 PREDICTORS OF SKELETAL RELATED EVENTS AND OVERALL MORTALITY IN MEN WITH METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2019) (0)
Title Is clinical stage T 2 c prostate cancer an intermediate-or high-risk disease ? (2015) (0)
Basal-Luminal Hybrid Cells Emerge as a New Dormant, Androgen Pathway Directed Therapy-Resistant Population in Patient-Derived Prostate Cancer Organoids (2021) (0)
TIMING OF PSA NADIR AFTER RADICAL PROSTATECTOMY AND RISK OF BIOCHEMICAL RECURRENCE: DOES IT MATTER? RESULTS FROM THE SEARCH DATABASE: MP47‐09 (2017) (0)
IMPACT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION ON OUTCOMES AFTER AORTIC VALVE REPLACEMENT (2019) (0)
964 CIGARETTE SMOKING IS ASSOCIATED WITH SHORTER TIME FROM RADICAL PROSTATECTOMY TO METASTASIS: RESULTS FROM THE SEARCH DATABASE (2013) (0)
679 LOW SERUM FOLATE IS A RISK FACTOR FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY RESULTS FROM THE SEARCH DATABASE (2012) (0)
MP68-18 ENZALUTAMIDE TREATMENT RESULTS IN ANTI-ANDROGEN RESISTANCE IN PATIENT-DERIVED BONE METASTATIC PROSTATE CANCER MODELS (2019) (0)
DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP (2009) (0)
S&T-12 RACE DOES NOT PREDICT THE DEVELOPMENT OF METASTASES IN MEN WITH NON-METASTATIC CASTRATE RESISTANT PROSTATE CANCER (2016) (0)
1103: Epigenetics of Beta-Catenin Gene is Involved in the Progression and Metastasis of Prostate Cancer (2004) (0)
Robotic Pelvic Lymphadenectomy: Standard and Extended Techniques (2017) (0)
Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort. (2023) (0)
COMMENT ON : METASTATIC ADENOCARCINOMA OF THE PROSTATE TO THE CHOROID WITHLOSS OF VISUAL ACUITY AS A PRESENTING SYMPTOM BY KEIZUR J. ET AL (1999) (0)
PD28-12 SAFETY OF TESTOSTERONE REPLACEMENT THERAPY AFTER RADICAL PROSTATECTOMY (RP) FOR LOCALIZED PROSTATE CANCER: A POPULATION-BASED ANALYSIS (2019) (0)
PD24-02 ASSOCIATIONS OF 5&agr;-REDUCTASE INHIBITORS WITH DELAYED PROSTATE CANCER DIAGNOSIS AND INCREASED PROSTATE CANCER MORTALITY (2019) (0)
PD07-04 PRE-CLINICAL STUDIES FOR ADVANCING CIRMTUZUMAB-BASED ANTI-ROR1 THERAPIES IN METASTATIC PROSTATE CANCER (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Christopher J. Kane?

Christopher J. Kane is affiliated with the following schools:

University of California, San Diego
University of California, San Francisco
University of Pennsylvania

Christopher J. Kane's Academic­Influence.com Rankings

Christopher J. Kane's Degrees

Why Is Christopher J. Kane Influential?

Christopher J. Kane's Published Works

Published Works

What Schools Are Affiliated With Christopher J. Kane?

Christopher J. Kane's AcademicInfluence.com Rankings